<table>
 <tbody><tr style="FONT-SIZE:1PX">
 <td width="5%" valign="TOP">
 <p>&nbsp;</p>
 </td>
 <td width="95%" valign="TOP">
 <p>&nbsp;</p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="2">At September 30, 2008 there were no unvested stock
 option awards and all compensation expense had been fully recognized. </font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="2"><i>Warrants</i></font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="2">At September 30, 2008 and March 31, 2008, there were
 outstanding warrants to purchase an aggregate of 40,766 shares of common
 stock at an exercise price per share of $3.68 held by one individual. These
 warrants expire on April 30, 2010.</font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="2"><i>Non-Vested
 Stock </i></font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="2">As of September 30, 2008, pursuant to the
 authorization of the Company’s Board of Directors and certain Restricted
 Stock Agreements, the Company had awarded 619,006 shares of common stock
 under the Company’s 2002 Plan to certain employees. Grant date fair value is
 determined by the market price of the Company’s common stock on the date of
 grant. The aggregate value of these shares at their respective grant dates
 amounted to $1,584,761 and will be recognized ratably as compensation expense
 over the vesting periods. The shares of common stock granted pursuant to such
 agreements vest in various tranches over five years from the date of grant.</font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="2">The shares awarded under the restricted stock
 agreements vest on the applicable vesting dates only to the extent the
 recipient of the shares is then an employee of the Company or one of its
 subsidiaries, and each recipient will forfeit all of the shares that have not
 vested on the date his or her employment is terminated. </font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 </tr>
 <tr>
 <td valign="TOP">
 <p><font size="1">&nbsp;</font></p>
 </td>
 <td valign="TOP">
 <p><font size="2">As of September 30, 2008, pursuant to the
 authorization of the Company’s Board of Directors and certain Restricted
 Stock Agreements, the Company had awarded 369,767 shares of common stock that
 were not issued under the Company’s 2002 Plan. These shares include an award
 of 200,000 shares to the Company’s Chief Executive Officer. </font></p>
 </td>
 </tr>
</tbody></table>
<table>
<tbody><tr>
<td>
<p> </p>
</td>
<td>
<p> </p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font>At September 30, 2008 there were no unvested stock
 option awards and all compensation expense had been fully recognized. </font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font> </font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font><i>Warrants</i></font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font> </font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font>At September 30, 2008 and March 31, 2008, there were
 outstanding warrants to purchase an aggregate of 40,766 shares of common
 stock at an exercise price per share of $3.68 held by one individual. These
 warrants expire on April 30, 2010.</font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font> </font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font><i>Non-Vested
 Stock </i></font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font> </font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font>As of September 30, 2008, pursuant to the
 authorization of the Company’s Board of Directors and certain Restricted
 Stock Agreements, the Company had awarded 619,006 shares of common stock
 under the Company’s 2002 Plan to certain employees. Grant date fair value is
 determined by the market price of the Company’s common stock on the date of
 grant. The aggregate value of these shares at their respective grant dates
 amounted to $1,584,761 and will be recognized ratably as compensation expense
 over the vesting periods. The shares of common stock granted pursuant to such
 agreements vest in various tranches over five years from the date of grant.</font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font> </font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font>The shares awarded under the restricted stock
 agreements vest on the applicable vesting dates only to the extent the
 recipient of the shares is then an employee of the Company or one of its
 subsidiaries, and each recipient will forfeit all of the shares that have not
 vested on the date his or her employment is terminated. </font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font> </font></p>
</td>
</tr>
<tr>
<td>
<p><font> </font></p>
</td>
<td>
<p><font>As of September 30, 2008, pursuant to the
 authorization of the Company’s Board of Directors and certain Restricted
 Stock Agreements, the Company had awarded 369,767 shares of common stock that
 were not issued under the Company’s 2002 Plan. These shares include an award
 of 200,000 shares to the Company’s Chief Executive Officer. </font></p>
</td>
</tr>
</tbody></table>